Pulse Biosciences Grants Equity Incentive Awards To New Employees

Pulse Biosciences, Inc. (Nasdaq: PLSE) (Pulse Biosciences or the Company) a novel bioelectric medicine company progressing Nano-Pulse Stimulation (NPS) technology, today announced that the Compensation Committee of the Companys Board of Directors granted non-qualified stock options covering an aggregate of 77,250 shares of Pulse Biosciences common stock to recently hired non-executive employees under the Pulse Biosciences 2017 Inducement Equity Incentive Plan on September 15, 2020.